PMCB / PharmaCyte Biotech, Inc. - Layar Saham

PharmaCyte Biotech, Inc.
US ˙ NasdaqCM ˙ US71715X2036

PMCB / PharmaCyte Biotech, Inc. - Layar Saham

Daftar ini menunjukkan semua penyaring saham buatan Fintel yang saat ini memuat sekuritas ini.

NCAV Screen
The Net Current Asset Value (NCAV) is a conservative valuation metric popularized by Benjamin Graham. To calculate it, simply subtract the total liabilities from a company’s current assets. To calculate NCAVPS (Net Current Asset Value Per Share), divide the NCAV by the number outstanding shares. This stock screener takes Ben Graham’s more conservative approach and uses ⅔ of the NCAV.
NNWC (Benjamin Graham's Net Net) Screen
This is Benjamin Graham's Net Net Working Capital Screen
Negative Enterprise Value Companies
Companies with negative enterprise value generally get this way because they have a lot of cash. (Cash is subtracted when calculating EV). There is some evidence that negative enterprise value companies outperform the market, so companies matching this screen might be undervalued.
The Enterprise Multiple (Nano Cap)
The Enterprise Multiple is a metric used in valuation, equal to Enterprise Value divided by Operating Income. As it accounts for debt, the Enterprise Multiple analyzes a firm from the perspective of a would-be acquirer.
The Magic Formula
The Magic Formula screen essentially ranks stocks on two metrics: low relative cost ("cheap") and high returns on capital ("quality" or "good").
The Enterprise Multiple (< 5, All Stocks)
The Enterprise Multiple is a metric used in valuation, equal to Enterprise Value divided by Operating Income. As it accounts for debt, the Enterprise Multiple analyzes a firm from the perspective of a would-be acquirer.
The Magic Formula (Nano Cap)
The Magic Formula screen essentially ranks nano cap stocks on two metrics: low relative cost ("cheap") and high returns on capital ("quality" or "good").
Earnings Yield (> 30%)
Stocks with a high Earnings Yield.
Microcap Value Dump
Microcap Value Dump
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista